Cargando…
Molecular correlates of cisplatin-based chemotherapy response in muscle invasive bladder cancer by integrated multi-omics analysis
Overtreatment with cisplatin-based chemotherapy is a major issue in the management of muscle-invasive bladder cancer (MIBC), and currently none of the reported biomarkers for predicting response have been implemented in the clinic. Here we perform a comprehensive multi-omics analysis (genomics, tran...
Autores principales: | Taber, Ann, Christensen, Emil, Lamy, Philippe, Nordentoft, Iver, Prip, Frederik, Lindskrog, Sia Viborg, Birkenkamp-Demtröder, Karin, Okholm, Trine Line Hauge, Knudsen, Michael, Pedersen, Jakob Skou, Steiniche, Torben, Agerbæk, Mads, Jensen, Jørgen Bjerggaard, Dyrskjøt, Lars |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7519650/ https://www.ncbi.nlm.nih.gov/pubmed/32978382 http://dx.doi.org/10.1038/s41467-020-18640-0 |
Ejemplares similares
-
Author Correction: Molecular correlates of cisplatin-based chemotherapy response in muscle invasive bladder cancer by integrated multi-omics analysis
por: Taber, Ann, et al.
Publicado: (2022) -
SPTAN1, APC, and FGFR3 Mutation Status and APOBEC Mutation Signatures are Predictive of Mitomycin C Response in Non-muscle-invasive Bladder Cancer
por: Lindgren, Maria Skydt, et al.
Publicado: (2021) -
Cell-Free Urine and Plasma DNA Mutational Analysis Predicts Neoadjuvant Chemotherapy Response and Outcome in Patients with Muscle-Invasive Bladder Cancer
por: Christensen, Emil, et al.
Publicado: (2023) -
Optimized targeted sequencing of cell-free plasma DNA from bladder cancer patients
por: Christensen, Emil, et al.
Publicado: (2018) -
Single-nucleus and Spatially Resolved Intratumor Subtype Heterogeneity in Bladder Cancer
por: Lindskrog, Sia V., et al.
Publicado: (2023)